A1 adenosine receptor-mediated Ins(1,4,5)P3 generation in allergic rabbit airway smooth muscle.
The signal transduction pathway for A1 adenosine receptor in airway smooth muscle from allergic rabbits was studied by investigating the effect of the selective A1 adenosine-receptor agonist N6-cyclopentyladenosine (CPA) on tissue levels of inositol 1,4, 5-trisphosphate [Ins(1,4,5)P3] measured by protein binding assay. CPA caused a rapid, transient, and concentration-dependent elevation of Ins(1,4,5)P3 in airways from allergic rabbits. The agonist also produced a concentration-dependent contraction of the airway preparations from these animals. Both the Ins(1,4,5)P3 and contractile responses generated by CPA were attenuated by the phospholipase C (PLC) inhibitor U-73122, indicating the coupling of these responses to PLC. The CPA-induced Ins(1,4,5)P3 production observed in the allergic rabbit tissues was also inhibited by the adenosine-receptor antagonist 8-( p-sulfophenyl)-theophylline, suggesting that the effect was mediated by A1 adenosine receptors. On the other hand, the A2 adenosine-receptor agonist CGS-21680 was ineffective in altering the tissue concentration of Ins(1,4,5)P3, indicating that A2 adenosine receptors may not be involved in the activation of PLC in the allergic rabbit airway smooth muscle. In this preparation, the Gi-Go inhibitor pertussis toxin (PTX) attenuated the CPA-induced Ins(1,4,5)P3 accumulation, providing evidence that the generation of Ins(1,4,5)P3 by A1 adenosine-receptor stimulation is coupled to a PTX-sensitive G protein(s). The results suggest that activation of A1 adenosine receptors in allergic rabbit airway smooth muscle causes the production of Ins(1,4,5)P3 via a PTX-sensitive G protein-coupled PLC, and this signaling mechanism may be involved, at least in part, in the generation of contractile responses. It is hypothesized that this process may contribute to adenosine-induced bronchoconstriction in allergic asthma.
Abebe
W
W
Department of Pharmacology, School of Medicine, East Carolina University, Greenville, North Carolina 27858, USA.
Mustafa
S J
SJ
D000241:Adenosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000403:Airway Resistance / Q000502:physiology; D000485:Allergens / Q000276:immunology; D000818:Animals; D001249:Asthma / Q000503:physiopathology*; D001980:Bronchi / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology*; D004391:Dust; D004963:Estrenes / Q000494:pharmacology; D007073:Immunoglobulin E / Q000096:biosynthesis; D066298:In Vitro Techniques; D015544:Inositol 1,4,5-Trisphosphate / Q000378:metabolism*; D008170:Lung Compliance / Q000502:physiology; D008925:Mites / Q000276:immunology; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology*; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology*; D010627:Phenethylamines / Q000494:pharmacology; D058906:Purinergic P1 Receptor Agonists; D011760:Pyrrolidinones / Q000494:pharmacology; D011817:Rabbits; D018047:Receptors, Purinergic P1 / Q000502:physiology*; D012130:Respiratory Hypersensitivity / Q000503:physiopathology*
D000485:Allergens; D004391:Dust; D004963:Estrenes; D010627:Phenethylamines; D058906:Purinergic P1 Receptor Agonists; D011760:Pyrrolidinones; D018047:Receptors, Purinergic P1; C060229:1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione; C061282:2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine; D007073:Immunoglobulin E; C048599:N(6)-cyclopentyladenosine; D015544:Inositol 1,4,5-Trisphosphate; D000241:Adenosine